178 related articles for article (PubMed ID: 7484753)
21. Adhesion molecules in different treatments of acute myocardial infarction.
Kerner T; Ahlers O; Reschreiter H; Bührer C; Möckel M; Gerlach H
Crit Care; 2001; 5(3):145-50. PubMed ID: 11353931
[TBL] [Abstract][Full Text] [Related]
22. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
23. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction.
Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y
Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755
[TBL] [Abstract][Full Text] [Related]
24. Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy.
Tamis-Holland JE; Palazzo A; Stebbins AL; Slater JN; Boland J; Ellis SG; Hochman JS;
Am Heart J; 2004 Jan; 147(1):133-9. PubMed ID: 14691431
[TBL] [Abstract][Full Text] [Related]
25. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis.
Huber K; Jörg M; Probst P; Schuster E; Lang I; Kaindl F; Binder BR
Thromb Haemost; 1992 Feb; 67(2):209-13. PubMed ID: 1621240
[TBL] [Abstract][Full Text] [Related]
26. Changes in plasma levels of tissue plasminogen activator and its inhibitor in aged myocardial infarction patients.
Chen HZ; Jia HY; Song HY; Wang JY
Chin Med J (Engl); 1990 Jul; 103(7):541-5. PubMed ID: 2119970
[TBL] [Abstract][Full Text] [Related]
27. Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
Am J Cardiol; 1996 Jul; 78(1):19-25. PubMed ID: 8712112
[TBL] [Abstract][Full Text] [Related]
28. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
[TBL] [Abstract][Full Text] [Related]
30. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
[TBL] [Abstract][Full Text] [Related]
31. The effects of the angiotensin-converting enzyme inhibitor imidapril on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction.
Oshima S; Ogawa H; Mizuno Y; Yamashita S; Noda K; Saito T; Sumida H; Suefuji H; Kaikita K; Soejima H; Yasue H
Am Heart J; 1997 Nov; 134(5 Pt 1):961-6. PubMed ID: 9398110
[TBL] [Abstract][Full Text] [Related]
32. A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty.
Wehrens XH; Doevendans PA; Ophuis TJ; Wellens HJ
Am Heart J; 2000 Mar; 139(3):430-6. PubMed ID: 10689257
[TBL] [Abstract][Full Text] [Related]
33. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.
Simoons ML; Arnold AE; Betriu A; de Bono DP; Col J; Dougherty FC; von Essen R; Lambertz H; Lubsen J; Meier B
Lancet; 1988 Jan; 1(8579):197-203. PubMed ID: 2893037
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
[TBL] [Abstract][Full Text] [Related]
35. [Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct].
Bruna C; Vado A; Rossetti G; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Uslenghi E
G Ital Cardiol; 1997 Nov; 27(11):1144-52. PubMed ID: 9463058
[TBL] [Abstract][Full Text] [Related]
36. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction.
Hasdai D; Lerman A; Rihal CS; Criger DA; Garratt KN; Betriu A; White HD; Topol EJ; Granger CB; Ellis SG; Califf RM; Holmes DR
Am Heart J; 1999 Apr; 137(4 Pt 1):612-20. PubMed ID: 10097222
[TBL] [Abstract][Full Text] [Related]
37. Difference in plasminogen activator inhibitor activity between non-Q-wave infarction and Q-wave infarction.
Ogawa H; Misumi I; Sakamoto T; Masuda T; Okubo H; Miyao Y; Yasue H
Int J Cardiol; 1993 Oct; 41(3):201-8. PubMed ID: 8288409
[TBL] [Abstract][Full Text] [Related]
38. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
39. Patterns of myoglobin and MM creatine kinase isoforms release early after intravenous thrombolysis or direct percutaneous transluminal coronary angioplasty for acute myocardial infarction, and implications for the early noninvasive diagnosis of reperfusion.
Laperche T; Steg PG; Benessiano J; Dehoux M; Juliard JM; Himbert D; Gourgon R
Am J Cardiol; 1992 Nov; 70(13):1129-34. PubMed ID: 1414933
[TBL] [Abstract][Full Text] [Related]
40. Half-dose thrombolysis to begin with, when immediate coronary angioplasty in acute myocardial infarction is not possible.
La Scala E; Steffenino G; Dellavalle A; Baralis G; Meinardi F; Margaria F; Goletto S; Rolfo F
Ital Heart J; 2004 Sep; 5(9):678-83. PubMed ID: 15568596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
